Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • FISV vs GSK✓SelectedUSD · GSKFISV vs GSK performance historyLatest closeAs of-1.60%11/17
Stock and ETF performance explorer

FISV vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+13,104.7%
GSK return
+1,698.4%
Excess return
+11,406.3%
Maximum drawdown
-81.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.6%-2.3%+0.7%-0.8%
7D-1.6%-3.0%+1.4%-0.6%
30D+31.0%+0.4%+30.7%+30.8%
3M+19.3%-1.2%+20.5%+19.5%
6M+12.6%+0.9%+11.7%+11.8%
YTD-7.2%+4.0%-11.2%-9.2%
1Y-0.6%+7.3%-7.9%-3.7%
3Y-49.8%+57.1%-106.9%-59.0%
5Y-38.2%+43.0%-81.2%-48.6%
10Y+18.6%+103.1%-84.4%-12.8%
All+13,104.7%+1,698.4%+11,406.3%+6,015.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling